Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 155

Sort by

Sort Order Select

Journal Articles

Survival Benefits from Antifungal Prophylaxis and a Dedicated Inpatient Malignant Hematology Service during Induction Chemotherapy for Acute Myeloid Leukemia

Andrew Hsu, MD, Robert Matera, MD, John L. Reagan, MD, Dimitrios Farmakiotis, MD

Blood (2019) 134 (Supplement_1): 3436.

https://doi.org/10.1182/blood-2019-122264

Published: 2019

Journal Articles

Patterns of Care and Clinical Outcomes with 7+3 Induction Chemotherapy for Patients (pts) with Acute Myeloid Leukemia (AML) in the United States (US): A Large Population-Based Study

Amer M. Zeidan, MBBS, MHS, Nikolai A. Podoltsev, MD PhD, Xiaoyi Wang, MD MPH, Jan Philipp Bewersdorf, MD, Rory M Shallis, MD, Scott F. Huntington, MD MPH, Natalia Neparidze, MD, Smith Giri, MBBS, MHS, Steven D. Gore, MD, Xiaomei Ma, PhD, Amy J Davidoff, PhD MS, Rong Wang, PhD

Blood (2019) 134 (Supplement_1): 116.

https://doi.org/10.1182/blood-2019-126643

Published: 2019

Journal Articles

Incidence of Invasive Fungal Infections in Acute Leukemia Patients Utilizing Micafungin Prophylaxis Compared to Second-Generation Azole Prophylaxis

Heather Morris, PharmD, BCPS, Meredith T. Moorman, PharmD, BCOP, CPP, Melissa C. Mackey, PharmD, BCPS, BCOP, Harry P. Erba, MD PhD, Thomas W. LeBlanc, MDMA,MHS, David A. Rizzieri, MD, Ian Barak, MS, Zhiguo Li, PhD, Tanya Zapolskaya, PharmD, BCPS, BCOP

Blood (2019) 134 (Supplement_1): 5105.

https://doi.org/10.1182/blood-2019-132197

Published: 2019

Journal Articles

Combination of Venetoclax and Hypomethylating Agents in Myeloid Malignancies in Patients Unfit for Intensive Chemotherapy - Real World Data from a Tertiary Care Centre in India. Is It Time to Bid Adieu to 3+7?

Sumeet Prakash Mirgh, MBBS, MDDM, Jyotsna Kapoor, MSc, Shinto Francis Thekuddan, MD DM, Vishvdeep Khushoo, MBBS, MDDM, Faran Naim, MD DNB, Ambar Garg, MD DNB, Narendra Agrawal, MD DM, Rayaz Ahmed, MDDM, Dinesh Bhurani, MD DM, FRCPA

Blood (2019) 134 (Supplement_1): 5149.

https://doi.org/10.1182/blood-2019-131746

Published: 2019

Journal Articles

Off-Label Use of Venetoclax Combination Therapy in Relapsed/Refractory Acute Myeloid Leukemia: A Single Institution Experience

Daria Gaut, MD, Aaron Burkenroad, MD, Tuyen Duong, Jesse Feammelli, PharmD, Joshua Sasine, MD PhD, Gary J. Schiller, MD

Blood (2019) 134 (Supplement_1): 5133.

https://doi.org/10.1182/blood-2019-123071

Published: 2019

Journal Articles

Acute Myeloid Leukemia and Antifungal Prophylaxis Era: Compliance of AML Centers, Invasive Fungal Infection (IFI) Classification, IFI Incidence and AML Outcomes from ALFA 2007- 02 Study

Blood (2019) 134 (Supplement_1): 2618.

https://doi.org/10.1182/blood-2019-130642

Published: 2019

Journal Articles

Invasive Fungal Disease Following Myeloablative Cord Blood Transplantation for Patients with Hematological Malignancies

Duihong Li, Huang Jiafu, Xiaofan Li, MD PhD, Zheng Jing, Haiying Fu, Zhenshu Xu, MD, Yuanzhong Chen, MD PhD, Nainong LI

Blood (2019) 134 (Supplement_1): 5653.

https://doi.org/10.1182/blood-2019-126953

Published: 2019

Journal Articles

Risk Adapted Antifungal Strategy in Allogeneic Stem Cell Transplantation. Should We Change the Current Guidelines?

Lucrecia Yanez San Segundo, MD PhD, Noemi Fernandez Escalada, MD, Arancha Bermúdez, MD, Guillermo Martín Sánchez, MD, Sara García Avila, MD, Mónica López Duarte, MD, Mercedes Colorado, MD, Iñigo Romon, MD PhD, Carlos Richard, MD, Enrique M. Ocio, MD PhD

Blood (2019) 134 (Supplement_1): 5655.

https://doi.org/10.1182/blood-2019-130731

Published: 2019

Journal Articles

Infection-Related Morbidity Reduced Overall Survival in a Large Real-World Cohort of Transplant Ineligible Newly Diagnosed Myeloma Patients Treated with UK Standard of Care

Faouzi Djebbari, Fotios Panitsas, Catherine Prodger, Fearn Davies, Kieran Burton, Akhil Khera, Grant Vallance, B.Sc., PhD, Sally Moore, Jaimal Kothari, Andy Peniket, MD, Karthik Ramasamy, MD PhD

Blood (2019) 134 (Supplement_1): 4768.

https://doi.org/10.1182/blood-2019-128139

Published: 2019

Journal Articles

Hematological Cancer Consortium: Multi-Center Acute Myeloid Leukemia Registry Data from India

Blood (2018) 132 (Supplement 1): 4006.

https://doi.org/10.1182/blood-2018-99-116853

Published: 2018

Journal Articles

Patterns of Infection and Mortality Associated with Intensive AML Induction Therapy: 10 Year Experience from a Tertiary Cancer Centre in India

Hemanth Kumar, MBBS, MD, Nikita Mehra, MD DM, Prasanth Ganesan, MD DM, Venkatraman Radhakrishnan, MD DM, Manikandan Dhanushkodi, MD DM, Jayachandran P K, MD DM, Trivadi S Ganesan, MD DM, S Krupa Shankar, MD DM, Tenali Gnana Sagar, MD DM, Krishnarathinam Kannan, MD DM

Blood (2018) 132 (Supplement 1): 4008.

https://doi.org/10.1182/blood-2018-99-119919

Published: 2018

Journal Articles

Risk-Adapted Anti-Mould Prophylaxis Improves Supportive Care in Childhood Leukemia Patients

Roman Crazzolara, MD, Julia Hutter, Josef Fritz, MD, Christina Salvador, MD, Cornelia Lass-Flörl, MD, Gabriele Kropshofer, MD

Blood (2018) 132 (Supplement 1): 3971.

https://doi.org/10.1182/blood-2018-99-110104

Published: 2018

Journal Articles

Isavuconazole (ISAV) As Primary Anti-Fungal Prophylaxis in Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-Label, Prospective Study

Blood (2018) 132 (Supplement 1): 2674.

https://doi.org/10.1182/blood-2018-99-111727

Published: 2018

Journal Articles

Largest Reported Series of Adults Who Received Treatment with Eculizumab (ECU) for Hematopoietic Cell Transplantation-Associated Thrombotic Microangiopathy (TA-TMA). a Single Center Experience

Alan P Skarbnik, MD, Mary E Dilorenzo, APN, Michele Simone, APN, Scott D. Rowley, MD, David H. Vesole, MD PhD, Maribel Pereiras, Pharm D, Tracy Andrews, MSc, Andrew L. Pecora, MD, Michele L. Donato, MD

Blood (2018) 132 (Supplement 1): 3383.

https://doi.org/10.1182/blood-2018-99-113639

Published: 2018

Journal Articles

Ciprofloxacin Prophylaxis Does Not Affect Incidence of Clostridium Difficile Infection in Autologous Stem Cell Transplant Patients

Kyle Grose, PharmD, Karen K. Ballen, MD, Tamila L Kindwall-Keller, DO, Kathlene DeGregory, PharmD, BCOP, Gina Petroni, PhD, Gerald R. Donowitz, MD, Brian Wispelwey, MD, Costi Sifri, MD, Leonid Volodin, MD

Blood (2018) 132 (Supplement 1): 3435.

https://doi.org/10.1182/blood-2018-99-111990

Published: 2018

Journal Articles

Central Nervous System Fungal Infections in Children with Leukemia, Risk Factors and Outcome: A Multicentric Study

Rejin Kebudi, MD, Serap Karaman, MD, Hande Kizilocak, Zeynep Karakas, Melike Sezgin Evim, Bengü Demirag, Zuhre Kaya, Husniye Nese Yarali, Umran Caliskan, B.Sahin Karagun, Canan Albayrak, MD, Sebnem Yilmaz, Deniz Karapinar, Ekrem Unal, MD, Adalet Meral Gunes, Neryal Tahta, Zeliha Guzelkucuk, Ulker Kocak, MD, Tiraje Celkan, MD

Blood (2018) 132 (Supplement 1): 5169.

https://doi.org/10.1182/blood-2018-99-112712

Published: 2018

Journal Articles

Midostaurin in Combination with Idarubicin and Cytarabine (3+7) Induction for FLT3 Positive AML - Very High Complete Response Rates and Transition to Allogeneic Transplantation

Jacques Azzi, MD, Frank Cirrone, PharmD, Maher Abdul Hay, MD, David Kaminetzky, MD, Kenneth B. Hymes, MD, Maxim Kreditor, MD, Ahmad-Samer Al-Homsi, MD, Michael L. Grossbard, MD, Catherine Diefenbach, MD, Tibor Moskovits, MD, Shella Saint Fleur-Lominy, MD PhD, Bruce G. Raphael, MD, Raoul Tibes, MD PhD

Blood (2018) 132 (Supplement 1): 5216.

https://doi.org/10.1182/blood-2018-99-117314

Published: 2018

Journal Articles

Retrospective Analysis of Adults with Acute Myeloid Leukemia Treated with Venetoclax Plus Hypomethylating Agents at a Comprehensive Cancer Center

Matthew Tenold, MD BS, Benjamin Moskoff, PharmD, David Benjamin, MD, Brian A. Jonas, MD PhD

Blood (2018) 132 (Supplement 1): 1424.

https://doi.org/10.1182/blood-2018-99-119593

Published: 2018

Journal Articles

Cyclosporin Dosing and Toxicity Following Allogeneic Haematopoietic Stem Cell Transplant at Austin Health

Danielle H Robinson, Charlotte Hughes, BBiomedSci, MD, Simon Zhao-Xiong He, MBBS, FRACP, FRCPA, Andrew P. Grigg, MBBS, FRACP, FRCPA, MD

Blood (2018) 132 (Supplement 1): 5701.

https://doi.org/10.1182/blood-2018-99-116146

Published: 2018

Journal Articles

Invasive Fungal Infection in the Setting of Peripheral Blood Non-Manipulated Haploidentical Stem Cell Transplantation with Postransplant Cyclophosphamide

Nieves Dorado, MD, Gillen Oarbeascoa, MD, Miguel Argüello, MD, Pascual Balsalobre, PhD, David Serrano, MD, Carolina Martínez-Laperche, Rebeca Bailén, MD, Javier Anguita, MD PhD, Jose Luis Díez-Martín, MD PhD, Mi Kwon

Blood (2018) 132 (Supplement 1): 5710.

https://doi.org/10.1182/blood-2018-99-118765

Published: 2018

NARROW

Survival Benefits from Antifungal Prophylaxis and a Dedicated Inpatient Malignant Hematology Service during Induction Chemotherapy for Acute Myeloid Leukemia

Patterns of Care and Clinical Outcomes with 7+3 Induction Chemotherapy for Patients (pts) with Acute Myeloid Leukemia (AML) in the United States (US): A Large Population-Based Study

Incidence of Invasive Fungal Infections in Acute Leukemia Patients Utilizing Micafungin Prophylaxis Compared to Second-Generation Azole Prophylaxis

Combination of Venetoclax and Hypomethylating Agents in Myeloid Malignancies in Patients Unfit for Intensive Chemotherapy - Real World Data from a Tertiary Care Centre in India. Is It Time to Bid Adieu to 3+7?

Off-Label Use of Venetoclax Combination Therapy in Relapsed/Refractory Acute Myeloid Leukemia: A Single Institution Experience

Acute Myeloid Leukemia and Antifungal Prophylaxis Era: Compliance of AML Centers, Invasive Fungal Infection (IFI) Classification, IFI Incidence and AML Outcomes from ALFA 2007- 02 Study

Invasive Fungal Disease Following Myeloablative Cord Blood Transplantation for Patients with Hematological Malignancies

Risk Adapted Antifungal Strategy in Allogeneic Stem Cell Transplantation. Should We Change the Current Guidelines?

Infection-Related Morbidity Reduced Overall Survival in a Large Real-World Cohort of Transplant Ineligible Newly Diagnosed Myeloma Patients Treated with UK Standard of Care

Hematological Cancer Consortium: Multi-Center Acute Myeloid Leukemia Registry Data from India

Patterns of Infection and Mortality Associated with Intensive AML Induction Therapy: 10 Year Experience from a Tertiary Cancer Centre in India

Risk-Adapted Anti-Mould Prophylaxis Improves Supportive Care in Childhood Leukemia Patients

Isavuconazole (ISAV) As Primary Anti-Fungal Prophylaxis in Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-Label, Prospective Study

Largest Reported Series of Adults Who Received Treatment with Eculizumab (ECU) for Hematopoietic Cell Transplantation-Associated Thrombotic Microangiopathy (TA-TMA). a Single Center Experience

Ciprofloxacin Prophylaxis Does Not Affect Incidence of Clostridium Difficile Infection in Autologous Stem Cell Transplant Patients

Central Nervous System Fungal Infections in Children with Leukemia, Risk Factors and Outcome: A Multicentric Study

Midostaurin in Combination with Idarubicin and Cytarabine (3+7) Induction for FLT3 Positive AML - Very High Complete Response Rates and Transition to Allogeneic Transplantation

Retrospective Analysis of Adults with Acute Myeloid Leukemia Treated with Venetoclax Plus Hypomethylating Agents at a Comprehensive Cancer Center

Cyclosporin Dosing and Toxicity Following Allogeneic Haematopoietic Stem Cell Transplant at Austin Health

Invasive Fungal Infection in the Setting of Peripheral Blood Non-Manipulated Haploidentical Stem Cell Transplantation with Postransplant Cyclophosphamide

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only